Furthermore, to validate the elevated CCL5 mRNA expression in ccRCC samples, we inspected 290 paired ccRCC and normal tissues with clinicopathological records and follow-up data from the FUSCC cohort and designated the cluster as the discovery set. Here, CCL5 is linked to nonpapillary renal cell carcinoma.